It's no secret that finding funding isn't easy right now for biotech start-ups.
"The funding landscape is really hard," said Anne-Marie Maman, founding member and CEO of the Princeton-based medical device start-up Oxygense Inc. "A company that's just surviving during these times right now is really succeeding."
Nearly 30 start-ups and academic institutions, including Oxygense, tried to break through the icy investment scene last week by presenting their ideas to potential partners and investors at the Biotech 2011 Innovation Corridor.
To read the full, original article click on this link: Innovation Corridor helps forge critical connections - NJBIZ
